These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1392137)

  • 21. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.
    Koski CL
    Semin Neurol; 1994 Jun; 14(2):123-30. PubMed ID: 7984827
    [No Abstract]   [Full Text] [Related]  

  • 24. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
    Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
    Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
    [No Abstract]   [Full Text] [Related]  

  • 25. Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b.
    Marfia GA; Pachatz C; Terracciano C; Leone G; Bernardini S; Bernardi G; Massa R
    Neurol Sci; 2005 Dec; 26(5):355-7. PubMed ID: 16388373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split?
    Galassi G
    Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic mechanisms in chronic demyelinating diseases of the central and peripheral nervous system.
    Wucherpfennig KW; Weiner HL
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():105-16. PubMed ID: 2158131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic subacute demyelinating neuropathy and Hodgkin's disease. Description of a case with immunological study].
    Graus Ribas F; Cabré Roura M; Gómez Alonso J; Peres Serra J
    Rev Clin Esp; 1981 Sep; 162(6):305-6. PubMed ID: 7330328
    [No Abstract]   [Full Text] [Related]  

  • 29. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gm haplotypes in inflammatory demyelinating polyneuropathies.
    Feeney DJ; Pollard JD; McLeod JG; Stewart GJ; De Lange GG
    Ann Neurol; 1989 Dec; 26(6):790-2. PubMed ID: 2557797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peripheral nerve myelin antigen-specific T cells in human].
    Ota K; Shimizu Y; Ueda M; Akiyama N; Iwata M
    Rinsho Shinkeigaku; 1996 Jul; 36(7):898-901. PubMed ID: 8952362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
    Hartung HP; Heininger K; Toyka KV
    Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of inflammatory demyelinating neuropathies.
    Prineas JW
    Baillieres Clin Neurol; 1994 Apr; 3(1):1-24. PubMed ID: 7921584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effector mechanisms in demyelinating neuropathies.
    Hartung HP; Zielasek J; Jung S; Toyka KV
    Rev Neurol (Paris); 1996 May; 152(5):320-7. PubMed ID: 8881423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
    Bae JS; Kim BJ
    J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The remote effects of cancer on the nervous system.
    Dropcho EJ
    Neurol Clin; 1989 Aug; 7(3):579-603. PubMed ID: 2549361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inflammatory demyelinating neuropathy in neuroborreliosis].
    Zifko U; Wondrusch E; Machacek E; Grisold W
    Wien Med Wochenschr; 1995; 145(7-8):188-90. PubMed ID: 7610671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multifocal motor neuropathies with persistent conduction blocks: a form of inflammatory demyelinating neuropathy].
    Pouget J; Azulay JP; Boucraut J
    Rev Neurol (Paris); 1996 May; 152(5):370-4. PubMed ID: 8881432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy].
    Yanagihara C; Ihara M; Nishimura Y; Oka N
    Rinsho Shinkeigaku; 1999 Sep; 39(9):971-5. PubMed ID: 10614165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.